|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Pharmaceuticals in Australia |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Décembre 2005 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 86 pages | Août 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,pharmacovigilance
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,united kingdom,india,germany,thailand,nigeria,... |
| |
|
|
|
|
| 96 pages | Juillet 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...,banks
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,china,france,canada,bermuda,israel,japan,india,... |
| |
|
|
|
|
| 64 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,atherosclerosis,hypertension
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada |
| |
|
|
|
|
| 64 pages | Novembre 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,dyslipidemia,pharmaceutical,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada,poland |
| |
|
|
|
|
| 70 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
india,usa,china,france,united kingdom,malaysia,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once a company's freedom over pricing decisions was almost limitless, external pressure |
955,00 €
|
| |
| |
The Pharmaceutical industry in the 21st Century
150 pages | Octobre 1998 |
Does the 21st century herald the beginning of a genomics revolution? Which disease areas will provide the greatest growth potential and why? Which technologies have the greatest potential to max |
795,00 €
|
| |
| |
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
3 500,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Patient Power Outlook 2001
152 pages | Juillet 2001 |
The increase in patient power witnessed over the last decade has been driven by developments in healthcare systems, patient advocacy activity, the increasing influence of the media in healthcare issue |
955,00 €
|
| |
| |
The Pharmaceutical Profitability Outlook
150 pages | Février 1999 |
Is pharmaceutical profitability sustainable into the 21st century? “As the pharmaceutical industry finds itself at a crossroads, the strategic directions companies take will be pivotal in determini |
795,00 €
|
| |
| |
Global Pharmaceutical: a market, company and disease analysis
150 pages | Octobre 1998 |
What will drive pharmaceutical market growth into the 21st Century? What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies ar |
795,00 €
|
| |
| |
The Drug Delivery Outlook 2001
176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery.
Subseque |
955,00 €
|
| |
| |
Lifestyle Drugs Outlook to 2005
130 pages | Février 1999 |
Definition of lifestyle drugs : The disease, product and social characteristics that make a drug lifestyle drug.
Epidemiology : The patient potential for lifestyle drugs such as sexual dysfuncti |
795,00 €
|
| |
| |
The Diagnostics Outlook to 2005
130 pages | Février 1999 |
Diagnostic market : The current in vitro diagnostic (IVD) market is discussed, identifying how the market can be segmented according to country, end user, clinical speciality and disease area.
795,00 €
|
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Pharmaceuticals in Australia |
|
|
Datamonitor's Pharmaceuticals in Australia industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of both ethical and over the-counter (OTC) drugs, but does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions have been made at the 2004 annual average exchange rate.
For the purposes of this report, Asia Pacific comprises Australia, China, India, Japan, South Korea and Taiwan.
Europe consists of Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
The global market is composed of Asia-Pacific, Europe, Brazil, Canada, Mexico, South Africa and the US.
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Competitive Landscape 12
CHAPTER 6 Leading Companies 13
6.1 Pfizer Inc 13
6.2 GlaxoSmithKline Plc 13
6.3 Merck & Co., Inc. 14
6.4 AstraZeneca PLC 14
6.5 Bristol-Myers Squibb Company 14
CHAPTER 7 Market Forecasts 15
7.1 Market Value Forecast 15
CHAPTER 8 Macroeconomic Indicators 16
CHAPTER 9 Further Reading 18
9.1 Sources 18
9.2 Related Datamonitor Research 18
LIST OF TABLES
Table 1: Australia Pharmaceuticals Market Value: $ billion, 2001-2005 9
Table 2: Australia Pharmaceuticals Market Segmentation I: % Share, by Value, 2005 10
Table 3: Australia Pharmaceuticals Market Segmentation II: % Share, by Value, 2005 11
Table 4: Australia Pharmaceuticals Market Value Forecast: $ billion, 2005-2010 15
Table 5: Australia Size of Population (million) , 2001-2005 16
Table 6: Australia GDP (1995=100), 2001-2005 16
Table 7: Australia Inflation, 2001-2005 16
Table 8: Australia Exchange Rate, 2001 17
??
??
??
??
CONTENTS
|
|
|
PPLSEN
|
|
|
|
|
